Eli Lilly Future Growth
Future criteria checks 5/6
Eli Lilly is forecast to grow earnings and revenue by 29.5% and 17.9% per annum respectively. EPS is expected to grow by 30% per annum. Return on equity is forecast to be 57.4% in 3 years.
Key information
29.5%
Earnings growth rate
30.0%
EPS growth rate
Pharmaceuticals earnings growth | 0% |
Revenue growth rate | 17.9% |
Future return on equity | 57.4% |
Analyst coverage | Good |
Last updated | 12 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 69,852 | 24,938 | 18,304 | 22,415 | 25 |
12/31/2025 | 58,294 | 19,640 | 12,124 | 17,288 | 28 |
12/31/2024 | 45,653 | 11,307 | 8,684 | 11,901 | 27 |
9/30/2024 | 40,863 | 8,370 | -1,744 | 6,032 | N/A |
6/30/2024 | 38,923 | 7,342 | -2,024 | 4,510 | N/A |
3/31/2024 | 35,932 | 6,138 | -2,292 | 3,676 | N/A |
12/31/2023 | 34,124 | 5,240 | -1,548 | 4,240 | N/A |
9/30/2023 | 32,073 | 4,988 | 1,469 | 6,215 | N/A |
6/30/2023 | 29,516 | 6,498 | 3,307 | 6,242 | N/A |
3/31/2023 | 27,691 | 5,687 | 3,881 | 6,793 | N/A |
12/31/2022 | 28,541 | 6,245 | 4,696 | 7,586 | N/A |
9/30/2022 | 29,240 | 6,033 | 5,404 | 8,080 | N/A |
6/30/2022 | 29,071 | 5,692 | 4,950 | 7,494 | N/A |
3/31/2022 | 29,323 | 6,129 | 5,824 | 8,086 | N/A |
12/31/2021 | 28,318 | 5,582 | 5,604 | 7,366 | N/A |
9/30/2021 | 27,759 | 5,972 | 4,621 | 6,919 | N/A |
6/30/2021 | 26,726 | 6,071 | 4,837 | 7,095 | N/A |
3/31/2021 | 25,486 | 6,093 | 5,565 | 7,815 | N/A |
12/31/2020 | 24,540 | 6,194 | 4,471 | 6,500 | N/A |
9/30/2020 | 23,214 | 5,573 | 5,112 | 6,648 | N/A |
6/30/2020 | 22,950 | 5,618 | 4,890 | 6,352 | N/A |
3/31/2020 | 23,087 | 5,533 | 3,684 | 4,908 | N/A |
12/31/2019 | 22,320 | 4,638 | 3,483 | 4,837 | N/A |
9/30/2019 | 21,843 | 4,264 | 2,671 | 4,322 | N/A |
6/30/2019 | 21,673 | 4,103 | 3,324 | 4,933 | N/A |
3/31/2019 | 21,622 | 2,545 | 2,217 | 5,399 | N/A |
12/31/2018 | 21,493 | 3,151 | 2,506 | 5,525 | N/A |
9/30/2018 | 22,016 | 372 | 2,100 | 5,819 | N/A |
6/30/2018 | 22,368 | -166 | N/A | 5,579 | N/A |
3/31/2018 | 22,607 | 1,074 | N/A | 5,712 | N/A |
12/31/2017 | 19,974 | -86 | N/A | 5,616 | N/A |
9/30/2017 | 22,471 | 2,225 | N/A | 5,879 | N/A |
6/30/2017 | 22,005 | 2,447 | N/A | 5,659 | N/A |
3/31/2017 | 21,585 | 2,187 | N/A | 5,410 | N/A |
12/31/2016 | 21,222 | 2,738 | N/A | 4,851 | N/A |
9/30/2016 | 20,837 | 2,444 | N/A | 3,841 | N/A |
6/30/2016 | 20,605 | 2,466 | N/A | 3,284 | N/A |
3/31/2016 | 20,179 | 2,319 | N/A | 2,830 | N/A |
12/31/2015 | 19,959 | 2,408 | N/A | 2,965 | N/A |
9/30/2015 | 19,704 | 2,359 | N/A | 3,318 | N/A |
6/30/2015 | 19,620 | 2,059 | N/A | 3,905 | N/A |
3/31/2015 | 19,577 | 2,192 | N/A | 4,010 | N/A |
12/31/2014 | 19,616 | 2,391 | N/A | 4,458 | N/A |
9/30/2014 | 20,303 | 2,690 | N/A | 4,744 | N/A |
6/30/2014 | 21,200 | 3,392 | N/A | 5,045 | N/A |
3/31/2014 | 22,194 | 3,865 | N/A | 5,628 | N/A |
12/31/2013 | 23,113 | 4,685 | N/A | 5,735 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: LLY's forecast earnings growth (29.5% per year) is above the savings rate (5.5%).
Earnings vs Market: LLY's earnings (29.5% per year) are forecast to grow faster than the CL market (11.4% per year).
High Growth Earnings: LLY's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: LLY's revenue (17.9% per year) is forecast to grow faster than the CL market (5.8% per year).
High Growth Revenue: LLY's revenue (17.9% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: LLY's Return on Equity is forecast to be very high in 3 years time (57.4%).